MedTrace Logo

Post-market Prospective Clinical Study of Nagor Perle Mammary Implants

NCT06013514 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2025-07-11

No results posted yet for this study

Summary

Patients can undergo breast implant surgery for multiple reasons; cosmetic and reconstructive being the primary indications. In order to confidently state safety and due to strict regulation on medical devices it is important to maintain a record of safety and performance with all medical implants.

This study is designed to collect data on a new generation of smooth mammary implants to assess the long term performance and safety data on this type of gel-filled mammary breast implant.

The two main complications of breast implants are capsular contracture and rupture; these complications can take years to develop. The study is designed to evaluate the occurrence of these two primary complication as well as other secondary complications over a period of 10 years. Patient follow up will be carried out pre-operatively and post operatively at 12 months and then 3, 5, 8 and 10 years thereafter.

The study will be carried out over 10 years to adequately assess complications which may only occur over the lifetime of the device such as systemic complications

Conditions

  • Breast Reconstruction
  • Breast Reconstruction Following Mastectomy
  • Breast Revision
  • Breast Augmentation
  • Breast Reconstruction With Silicone Implants
  • Breast Reconstruction After Mastectomy
  • Breast Reconstruction Surgery
  • Breast Implants

Interventions

DEVICE

PERLE Sterile Smooth Opaque gel filled mammary implants

Sterile smooth opaque gel filled mammary implants will be implanted in adult women having breast surgery for either augmentation, reconstruction or revision surgery. Different ranges of implants will be used to suit patient needs

Sponsors & Collaborators

  • GC Aesthetics

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2038-09-30
Completion
2038-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06013514 on ClinicalTrials.gov